+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nucleic Acid Labeling Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 280 Pages
  • October 2024
  • Region: Global
  • Allied Market Research
  • ID: 6053953

Nucleic Acid Labeling Market

The nucleic acid labeling market was valued at $2.5 billion in 2023 and is projected to reach $5.1 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.

Nucleic acid labeling is a biomolecular technique that involves the attachment of a detectable marker to nucleic acids, both DNA and RNA. This technique enables the tracking, analysis, or study of the presence, distribution, quantity, or sequence of nucleic acid. It finds applications in gene expression analysis, in-situ hybridization, PCR assays, and single-molecule analysis.

Rise in focus on genomic research and surge in the popularity of precision medicine are the key drivers of the nucleic acid labeling market. In addition, the technique plays a crucial role in facilitating early disease detection and proactive treatments, which augments the market growth significantly. Furthermore, expansion of the point-of-care testing approach is fueling the requirement for nucleic acid labeling infrastructure and propelling the development of the market. To enhance the precision and effectiveness of labeling, the development of next-generation fluorescent probes and nanoparticle-based labels is becoming a prominent trend in the market. These labels exhibit high sensitivity, which is essential to improve the signal-to-noise ratio of the process.

However, the high cost of reagents & equipment required to accomplish nucleic acid labeling deters several small-scale laboratories and institutions from their procurement, which hampers the growth of the market. Moreover, increase in the shortage of skilled workforce to conduct the labeling technique limits its adoption and restrains the nucleic acid labeling market. Contrarily, rise in expenditure and investments in the biopharmaceutical industry is poised to present lucrative opportunities for the nucleic acid labeling market.

The technique is essential for the industry to discover, validate, and monitor the drugs, biomarkers, and therapeutic responses. According to IQVIA - an American professional consulting and biopharmaceutical development provider - the global funding for biopharmaceutical R&D upsurged from $61 billion in 2022 to $72 billion in 2023. Therefore, the nucleic acid labeling market is poised to witness several new avenues with increasing investments.

Segment Review

The nucleic acid labeling market is segmented into product, labeling techniques, application, and region. On the basis of product, the market is bifurcated into kits & reagents and services. Depending on labeling techniques, it is divided into PCR, nick translation, random primer, in-vitro transcription, reverse transcription, and end labelling. As per application, it is classified into DNA sequencing, PCR, FISH, microarray, in-situ hybridization, blotting, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the kits & reagents & reagents segment held a high share of the market in 2023.

Depending on labeling techniques, the PCR segment dominated the market in 2023.

As per application, the FISH segment was the highest shareholder in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players in the global nucleic acid labeling market include Merck & Co., Inc., PerkinElmer, Inc., New England Biolabs, Inc., F. Hoffmann La-Roche AG, Enzo Biochem Inc., GE Healthcare, Vector Laboratories, Inc., Promega Corporation, Agilent Technologies, and Thermo Fisher Scientific. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update* (with the purchase of an enterprise license)
  • 5 additional Company Profiles, pre- or post-purchase, as a free update.
  • Free Updated Version (once released) with the purchase of an enterprise user license.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • New Product Development/ Product Matrix of Key Players
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Product

  • Kits and Reagents
  • Services

By Labeling Techniques

  • PCR
  • Nick Translation
  • Random Primer
  • In Vitro Transcription
  • Reverse Transcription
  • End Labelling

By Application

  • DNA Sequencing
  • PCR
  • FISH
  • Microarray
  • In Situ Hybridization
  • Blotting
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Merck & Co., Inc.
  • PerkinElmer, Inc
  • New England Biolabs, Inc.
  • F. Hoffmann La-Roche AG
  • Enzo Biochem Inc.
  • GE Healthcare
  • vector laboratories, inc.
  • Promega Corporation
  • Agilent Technologies
  • Thermo Fisher Scientific

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: NUCLEIC ACID LABELING MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Kits And Reagents
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Services
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES
5.1. Market Overview
5.1.1 Market Size and Forecast, By Labeling Techniques
5.2. PCR
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Nick Translation
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Random Primer
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. In Vitro Transcription
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Reverse Transcription
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
5.7. End Labelling
5.7.1. Key Market Trends, Growth Factors and Opportunities
5.7.2. Market Size and Forecast, By Region
5.7.3. Market Share Analysis, By Country
CHAPTER 6: NUCLEIC ACID LABELING MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. DNA Sequencing
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. PCR
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. FISH
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Microarray
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. In Situ Hybridization
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
6.7. Blotting
6.7.1. Key Market Trends, Growth Factors and Opportunities
6.7.2. Market Size and Forecast, By Region
6.7.3. Market Share Analysis, By Country
6.8. Others
6.8.1. Key Market Trends, Growth Factors and Opportunities
6.8.2. Market Size and Forecast, By Region
6.8.3. Market Share Analysis, By Country
CHAPTER 7: NUCLEIC ACID LABELING MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Labeling Techniques
7.2.4. Market Size and Forecast, By Application
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Nucleic Acid Labeling Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Labeling Techniques
7.2.6.3. Market Size and Forecast, By Application
7.2.7. Canada Nucleic Acid Labeling Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Labeling Techniques
7.2.7.3. Market Size and Forecast, By Application
7.2.8. Mexico Nucleic Acid Labeling Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Labeling Techniques
7.2.8.3. Market Size and Forecast, By Application
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Labeling Techniques
7.3.4. Market Size and Forecast, By Application
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Nucleic Acid Labeling Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Labeling Techniques
7.3.6.3. Market Size and Forecast, By Application
7.3.7. France Nucleic Acid Labeling Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Labeling Techniques
7.3.7.3. Market Size and Forecast, By Application
7.3.8. UK Nucleic Acid Labeling Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Labeling Techniques
7.3.8.3. Market Size and Forecast, By Application
7.3.9. Italy Nucleic Acid Labeling Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Labeling Techniques
7.3.9.3. Market Size and Forecast, By Application
7.3.10. Spain Nucleic Acid Labeling Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Labeling Techniques
7.3.10.3. Market Size and Forecast, By Application
7.3.11. Rest Of Europe Nucleic Acid Labeling Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Labeling Techniques
7.3.11.3. Market Size and Forecast, By Application
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Labeling Techniques
7.4.4. Market Size and Forecast, By Application
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Nucleic Acid Labeling Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Labeling Techniques
7.4.6.3. Market Size and Forecast, By Application
7.4.7. China Nucleic Acid Labeling Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Labeling Techniques
7.4.7.3. Market Size and Forecast, By Application
7.4.8. Australia Nucleic Acid Labeling Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Labeling Techniques
7.4.8.3. Market Size and Forecast, By Application
7.4.9. India Nucleic Acid Labeling Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Labeling Techniques
7.4.9.3. Market Size and Forecast, By Application
7.4.10. South Korea Nucleic Acid Labeling Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Labeling Techniques
7.4.10.3. Market Size and Forecast, By Application
7.4.11. Rest of Asia-Pacific Nucleic Acid Labeling Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Labeling Techniques
7.4.11.3. Market Size and Forecast, By Application
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Labeling Techniques
7.5.4. Market Size and Forecast, By Application
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Nucleic Acid Labeling Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Labeling Techniques
7.5.6.3. Market Size and Forecast, By Application
7.5.7. Saudi Arabia Nucleic Acid Labeling Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Labeling Techniques
7.5.7.3. Market Size and Forecast, By Application
7.5.8. South Africa Nucleic Acid Labeling Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Labeling Techniques
7.5.8.3. Market Size and Forecast, By Application
7.5.9. Rest of LAMEA Nucleic Acid Labeling Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Labeling Techniques
7.5.9.3. Market Size and Forecast, By Application
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Merck And Co., Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. PerkinElmer, Inc
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. New England Biolabs, Inc.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. F. Hoffmann La-Roche AG
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Enzo Biochem Inc.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. GE Healthcare
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Vector Laboratories, Inc.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Promega Corporation
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Agilent Technologies
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Thermo Fisher Scientific
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 2. Nucleic Acid Labeling Market for Kits and Reagents, by Region, 2024 - 2033 ($Billion)
Table 3. Nucleic Acid Labeling Market for Services, by Region, 2024 - 2033 ($Billion)
Table 4. Global Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 5. Nucleic Acid Labeling Market for Pcr, by Region, 2024 - 2033 ($Billion)
Table 6. Nucleic Acid Labeling Market for Nick Translation, by Region, 2024 - 2033 ($Billion)
Table 7. Nucleic Acid Labeling Market for Random Primer, by Region, 2024 - 2033 ($Billion)
Table 8. Nucleic Acid Labeling Market for in Vitro Transcription, by Region, 2024 - 2033 ($Billion)
Table 9. Nucleic Acid Labeling Market for Reverse Transcription, by Region, 2024 - 2033 ($Billion)
Table 10. Nucleic Acid Labeling Market for End Labelling, by Region, 2024 - 2033 ($Billion)
Table 11. Global Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 12. Nucleic Acid Labeling Market for DNA Sequencing, by Region, 2024 - 2033 ($Billion)
Table 13. Nucleic Acid Labeling Market for Pcr, by Region, 2024 - 2033 ($Billion)
Table 14. Nucleic Acid Labeling Market for Fish, by Region, 2024 - 2033 ($Billion)
Table 15. Nucleic Acid Labeling Market for Microarray, by Region, 2024 - 2033 ($Billion)
Table 16. Nucleic Acid Labeling Market for in Situ Hybridization, by Region, 2024 - 2033 ($Billion)
Table 17. Nucleic Acid Labeling Market for Blotting, by Region, 2024 - 2033 ($Billion)
Table 18. Nucleic Acid Labeling Market for Others, by Region, 2024 - 2033 ($Billion)
Table 19. Nucleic Acid Labeling Market, by Region, 2024 - 2033 ($Billion)
Table 20. North America Nucleic Acid Labeling Market, by Country, 2024 - 2033 ($Billion)
Table 21. North America Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 22. North America Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 23. North America Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 24. U.S. Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 25. U.S. Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 26. U.S. Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 27. Canada Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 28. Canada Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 29. Canada Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 30. Mexico Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 31. Mexico Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 32. Mexico Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 33. Europe Nucleic Acid Labeling Market, by Country, 2024 - 2033 ($Billion)
Table 34. Europe Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 35. Europe Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 36. Europe Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 37. Germany Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 38. Germany Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 39. Germany Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 40. France Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 41. France Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 42. France Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 43. UK Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 44. UK Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 45. UK Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 46. Italy Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 47. Italy Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 48. Italy Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 49. Spain Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 50. Spain Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 51. Spain Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 52. Rest of Europe Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 53. Rest of Europe Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 54. Rest of Europe Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 55. Asia-Pacific Nucleic Acid Labeling Market, by Country, 2024 - 2033 ($Billion)
Table 56. Asia-Pacific Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 57. Asia-Pacific Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 58. Asia-Pacific Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 59. Japan Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 60. Japan Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 61. Japan Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 62. China Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 63. China Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 64. China Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 65. Australia Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 66. Australia Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 67. Australia Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 68. India Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 69. India Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 70. India Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 71. South Korea Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 72. South Korea Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 73. South Korea Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 74. Rest of Asia-Pacific Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 75. Rest of Asia-Pacific Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 76. Rest of Asia-Pacific Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 77. LAMEA Nucleic Acid Labeling Market, by Country, 2024 - 2033 ($Billion)
Table 78. LAMEA Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 79. LAMEA Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 80. LAMEA Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 81. Brazil Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 82. Brazil Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 83. Brazil Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 84. Saudi Arabia Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 85. Saudi Arabia Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 86. Saudi Arabia Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 87. South Africa Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 88. South Africa Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 89. South Africa Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 90. Rest of LAMEA Nucleic Acid Labeling Market, by Product, 2024 - 2033 ($Billion)
Table 91. Rest of LAMEA Nucleic Acid Labeling Market, by Labeling Techniques, 2024 - 2033 ($Billion)
Table 92. Rest of LAMEA Nucleic Acid Labeling Market, by Application, 2024 - 2033 ($Billion)
Table 93. Merck and Co. Inc.: Key Executives
Table 94. Merck and Co. Inc.: Company Snapshot
Table 95. Merck and Co. Inc.: Operating Segments
Table 96. Merck and Co. Inc.: Product Portfolio
Table 97. Merck and Co. Inc.: Key Strategic Moves and Developments
Table 98. Perkinelmer, Inc.: Key Executives
Table 99. Perkinelmer, Inc.: Company Snapshot
Table 100. Perkinelmer, Inc.: Operating Segments
Table 101. Perkinelmer, Inc.: Product Portfolio
Table 102. Perkinelmer, Inc.: Key Strategic Moves and Developments
Table 103. New England Biolabs, Inc.: Key Executives
Table 104. New England Biolabs, Inc.: Company Snapshot
Table 105. New England Biolabs, Inc.: Operating Segments
Table 106. New England Biolabs, Inc.: Product Portfolio
Table 107. New England Biolabs, Inc.: Key Strategic Moves and Developments
Table 108. F. Hoffmann La-Roche AG: Key Executives
Table 109. F. Hoffmann La-Roche AG: Company Snapshot
Table 110. F. Hoffmann La-Roche AG: Operating Segments
Table 111. F. Hoffmann La-Roche AG: Product Portfolio
Table 112. F. Hoffmann La-Roche AG: Key Strategic Moves and Developments
Table 113. Enzo Biochem Inc.: Key Executives
Table 114. Enzo Biochem Inc.: Company Snapshot
Table 115. Enzo Biochem Inc.: Operating Segments
Table 116. Enzo Biochem Inc.: Product Portfolio
Table 117. Enzo Biochem Inc.: Key Strategic Moves and Developments
Table 118. GE Healthcare: Key Executives
Table 119. GE Healthcare: Company Snapshot
Table 120. GE Healthcare: Operating Segments
Table 121. GE Healthcare: Product Portfolio
Table 122. GE Healthcare: Key Strategic Moves and Developments
Table 123. Vector Laboratories, Inc.: Key Executives
Table 124. Vector Laboratories, Inc.: Company Snapshot
Table 125. Vector Laboratories, Inc.: Operating Segments
Table 126. Vector Laboratories, Inc.: Product Portfolio
Table 127. Vector Laboratories, Inc.: Key Strategic Moves and Developments
Table 128. Promega Corporation: Key Executives
Table 129. Promega Corporation: Company Snapshot
Table 130. Promega Corporation: Operating Segments
Table 131. Promega Corporation: Product Portfolio
Table 132. Promega Corporation: Key Strategic Moves and Developments
Table 133. Agilent Technologies: Key Executives
Table 134. Agilent Technologies: Company Snapshot
Table 135. Agilent Technologies: Operating Segments
Table 136. Agilent Technologies: Product Portfolio
Table 137. Agilent Technologies: Key Strategic Moves and Developments
Table 138. Thermo Fisher Scientific: Key Executives
Table 139. Thermo Fisher Scientific: Company Snapshot
Table 140. Thermo Fisher Scientific: Operating Segments
Table 141. Thermo Fisher Scientific: Product Portfolio
Table 142. Thermo Fisher Scientific: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Nucleic Acid Labeling Market, 2024 - 2033
Figure 2. Segmentation of Nucleic Acid Labeling Market, 2024 - 2033
Figure 3. Top Investment Pocket in Nucleic Acid Labeling Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalnucleic Acid Labeling Market
Figure 10. Global Nucleic Acid Labeling Market Segmentation, by Product
Figure 11. Nucleic Acid Labeling Market for Kits and Reagents, by Country, 2024 - 2033 ($Billion)
Figure 12. Nucleic Acid Labeling Market for Services, by Country, 2024 - 2033 ($Billion)
Figure 13. Global Nucleic Acid Labeling Market Segmentation, by Labeling Techniques
Figure 14. Nucleic Acid Labeling Market for Pcr, by Country, 2024 - 2033 ($Billion)
Figure 15. Nucleic Acid Labeling Market for Nick Translation, by Country, 2024 - 2033 ($Billion)
Figure 16. Nucleic Acid Labeling Market for Random Primer, by Country, 2024 - 2033 ($Billion)
Figure 17. Nucleic Acid Labeling Market for in Vitro Transcription, by Country, 2024 - 2033 ($Billion)
Figure 18. Nucleic Acid Labeling Market for Reverse Transcription, by Country, 2024 - 2033 ($Billion)
Figure 19. Nucleic Acid Labeling Market for End Labelling, by Country, 2024 - 2033 ($Billion)
Figure 20. Global Nucleic Acid Labeling Market Segmentation, by Application
Figure 21. Nucleic Acid Labeling Market for DNA Sequencing, by Country, 2024 - 2033 ($Billion)
Figure 22. Nucleic Acid Labeling Market for Pcr, by Country, 2024 - 2033 ($Billion)
Figure 23. Nucleic Acid Labeling Market for Fish, by Country, 2024 - 2033 ($Billion)
Figure 24. Nucleic Acid Labeling Market for Microarray, by Country, 2024 - 2033 ($Billion)
Figure 25. Nucleic Acid Labeling Market for in Situ Hybridization, by Country, 2024 - 2033 ($Billion)
Figure 26. Nucleic Acid Labeling Market for Blotting, by Country, 2024 - 2033 ($Billion)
Figure 27. Nucleic Acid Labeling Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 28. Top Winning Strategies, by Year, 2021-2023*
Figure 29. Top Winning Strategies, by Development, 2021-2023*
Figure 30. Top Winning Strategies, by Company, 2021-2023*
Figure 31. Product Mapping of Top 10 Players
Figure 32. Competitive Dashboard
Figure 33. Competitive Heatmap: Nucleic Acid Labeling Market
Figure 34. Top Player Positioning, 2023
Figure 35. Merck and Co. Inc.: Net Sales, 2021-2023 ($Billion)
Figure 36. Merck and Co. Inc.: Revenue Share, by Segment, 2023 (%)
Figure 37. Merck and Co. Inc.: Revenue Share, by Region, 2023 (%)
Figure 38. Perkinelmer, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 39. Perkinelmer, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 40. Perkinelmer, Inc.: Revenue Share, by Region, 2023 (%)
Figure 41. New England Biolabs, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 42. New England Biolabs, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 43. New England Biolabs, Inc.: Revenue Share, by Region, 2023 (%)
Figure 44. F. Hoffmann La-Roche AG: Net Sales, 2021-2023 ($Billion)
Figure 45. F. Hoffmann La-Roche AG: Revenue Share, by Segment, 2023 (%)
Figure 46. F. Hoffmann La-Roche AG: Revenue Share, by Region, 2023 (%)
Figure 47. Enzo Biochem Inc.: Net Sales, 2021-2023 ($Billion)
Figure 48. Enzo Biochem Inc.: Revenue Share, by Segment, 2023 (%)
Figure 49. Enzo Biochem Inc.: Revenue Share, by Region, 2023 (%)
Figure 50. GE Healthcare: Net Sales, 2021-2023 ($Billion)
Figure 51. GE Healthcare: Revenue Share, by Segment, 2023 (%)
Figure 52. GE Healthcare: Revenue Share, by Region, 2023 (%)
Figure 53. Vector Laboratories, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 54. Vector Laboratories, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 55. Vector Laboratories, Inc.: Revenue Share, by Region, 2023 (%)
Figure 56. Promega Corporation: Net Sales, 2021-2023 ($Billion)
Figure 57. Promega Corporation: Revenue Share, by Segment, 2023 (%)
Figure 58. Promega Corporation: Revenue Share, by Region, 2023 (%)
Figure 59. Agilent Technologies: Net Sales, 2021-2023 ($Billion)
Figure 60. Agilent Technologies: Revenue Share, by Segment, 2023 (%)
Figure 61. Agilent Technologies: Revenue Share, by Region, 2023 (%)
Figure 62. Thermo Fisher Scientific: Net Sales, 2021-2023 ($Billion)
Figure 63. Thermo Fisher Scientific: Revenue Share, by Segment, 2023 (%)
Figure 64. Thermo Fisher Scientific: Revenue Share, by Region, 2023 (%)

Companies Mentioned

  • Merck & Co., Inc.
  • PerkinElmer, Inc
  • New England Biolabs, Inc.
  • F. Hoffmann La-Roche AG
  • Enzo Biochem Inc.
  • GE Healthcare
  • vector laboratories, inc.
  • Promega Corporation
  • Agilent Technologies
  • Thermo Fisher Scientific

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information